Data manipulation and integrity issues have struck again as the FDA called out India's Sri Krishna Pharmaceuticals in a newly published warning letter,…

An announcement from the Chinese cabinet said today that 357 officials tied to the diversions of vaccine to a mother and daughter team who sold them outside…

Four years after U.K. regulators issued a ban on products from a Rusan Pharma site in India, inspectors found that nothing has changed, or at least not enough…

In 2008, contaminated raw heparin from China was tied to the deaths of dozens of U.S. dialysis patients, leading the FDA to realize it needed inspectors in…

India's Lupin said in a Bombay Stock Exchange filing on Tuesday that it had received four observations for two plants at its Mandideep site following a…

AstraZeneca had to recall inhalers in Denmark last year because some of them may have been empty. Now it's doing the same in the U.S. where some of its…

In a typical response to publicity that its pharma supply chain has been breached, China has rounded up dozens of suspects as it investigates an operation said…

It has been a tough few months for India's Cadila Healthcare. After having two plants slapped by the FDA with a warning letter, the Indian drugmaker…